Circulating Extracellular RNAs Linked to Insulin Resistance

Share this content:
Circulating Extracellular RNAs Linked to Insulin Resistance
Circulating Extracellular RNAs Linked to Insulin Resistance

TUESDAY, Feb. 14, 2017 (HealthDay News) -- Circulating extracellular RNAs (ex-RNAs) are associated with insulin resistance (IR), according to a study published online Feb. 9 in Diabetes Care.

Ravi Shah, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the correlation between ex-RNAs and metabolic phenotypes in 2,317 participants without diabetes in the Framingham Heart Study (FHS) Offspring Cohort. The correlation between candidate ex-RNAs and markers of adiposity was measured. Individuals with diabetes were included in sensitivity analyses. Selected ex-RNAs and metabolites were measured in a separate cohort of 90 overweight/obese youth.

The researchers found that across 391 ex-RNAs in FHS, 18 were associated with IR in age-, sex, and body mass index-adjusted models. Independent of metabolites, miR-122 correlated with IR and regional adiposity in adults and IR in children. Metabolic regulatory roles for miR-122, including regulation of IR pathways, was observed on pathway analysis.

"These results provide translational evidence in support of an important role of ex-RNAs as novel circulating factors implicated in IR," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »